Physician profile
Elliot Lach
NPI 1508876715
$1,944.20
in general payments reported to CMS, 2019-2025
9 companies · $301 in 2025
The $301 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $72.38 · 2023: $998 · 2024: $574 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,524 · Travel and Lodging: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,523.63 |
| Travel and Lodging | $348.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $811.61 | 2023-2025 | Recell, Cohealyx, Permeaderm |
| Organogenesis INC. | $305.34 | 2022-2025 | Apligraf, Puraply Antimicrobial |
| Smith+Nephew, INC. | $218.90 | 2023-2024 | Grafix Pl, Stravix Pl, Regranex |
| Merz North America, INC. | $148.24 | 2024 | |
| Reapplix INC. | $143.34 | 2025 | 3c Patch Kit - Box |
| Tactile Systems Technology INC | $115.50 | 2024 | Entre Plus, Flexitouch Plus |
| Hydrofera LLC | $115.10 | 2024 | Hydrofera Blue |
| Mimedx Group, INC. | $61.21 | 2024 | |
| Endo USA, INC. | $24.96 | 2024 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elliot Lach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.